Nitric oxide modulation of ETB receptor-induced vasopressin release by rat and mouse hypothalamo-neurohypophyseal explants

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 5, 2006, Pages

  Rossi, Noreen F ^a   Beierwaltes, William H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endothelin; Neuronal nitric oxide synthase; Nitric oxide synthase; Posterior pituitary

Indexed keywords

ENDOTHELIN B RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CONTROLLED STUDY; HYPOTHALAMUS; MALE; NEUROTRANSMISSION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; VASOPRESSIN RELEASE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELINS; ENZYME INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; RATS; RATS, LONG-EVANS; RECEPTOR, ENDOTHELIN B; VASOPRESSINS;

EID: 33646477704     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00701.2005     Document Type: Article

References (45)

1. + channels. J Physiol 520: 165-176, 1999.
2. Bains JS and Ferguson AV. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of the rat paraventricular nucleus. J Physiol 499: 733-746, 1997.
3. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 72: 387-395, 1993.
4. Cui LN, Inenaga K, Nagatoma T, and Yamashita H. Sodium nitroprusside modulates NMDA response in the rat supraoptic neurons in vitro. Brain Res Bull 35: 253-260, 1994.
5. Garthwaite J and Boulton CL. Nitric oxide signaling in the central nervous system. Annu Rev Physiol 57: 683-706, 1995.
6. Ghamari-Langroudi M and Bourque CW. Muscarinic receptor modulation of slow afterhyperpolarization and phasic firing in rat supraoptic nucleus neurons. J Neurosci 24: 7718-7726, 2004.
7. Gregg CM. Effect of cholinergic antagonists on basal and osmotically stimulated vasopressin release in compartmentalized hypothalamo-neurohypophysial explants. Neuroendocrinology 44: 378-383, 1986.
8. Gregg CM and Sladek CD. A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release. Neuroendocrinology 38: 397-402, 1984.
9. Huang PL, Dawson TM, Bredt DS, Snyder SH, and Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75: 1273-1286, 1993.
10. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Cristman BW, Weir EK, Eickelberg O, Voelkel NF, and Rabinovitch M. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43: 13S-24S, 2004.
11. Kadekaro M. Nitric oxide modulation of the hypothalamo-neurohypophyseal system. Braz J Med Biol Res 37: 441-450, 2004.
12. Kannan J, Tanaka H, Ueta Y, Hayashida Y, Kunitake T, and Yamashita H. Effects of centrally administered endothelin-3 on renal sympathetic nerve activity and renal blood flow in conscious rats. J Auton Nerv Syst 49: 105-113, 1994.
13. Kosecki C, Imai M, Hirata Y, Yanagisawa M, and Masaki T. Binding sites for endothelin-1 in rat tissues: an autoradiographic study. J Cardiovasc Pharmacol 5: S153-S154, 1989.
14. Liu QS, Jia YS, and Ju G. Nitric oxide inhibits neuronal activity in the supraoptic nucleus of the rat hypothalamic slices. Brain Res Bull 43: 121-125, 1997.
15. MacCumber MW, Ross CA, Glaser BM, and Masaki T. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86: 7285-7289, 1989.
16. Mosqueda-Garcia R, Inagami T, Appalsamy M, Sugiura M, and Robertson RM. Endothelin as a neuropeptide: Cardiovascular effects in the brainstem of normotensive rats. Circ Res 72: 20-35, 1992.
17. Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, and Uemura H. Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 132: 530-533, 1993.
18. Okere CO, Wang YF, Higuchi T, Negoro H, Okutani F, Takahashi S, and Murata T. The effect of systemic and central nitric oxide administration on milk availability in lactating rats. Neuroreport 8: 243-247, 1996.
19. Petzold GC, Einhaupl KM, Dirnagl Y, and Dreier JP. Ischemia triggered by spreading neuronal activation is induced by endothelin-1 and hemoglobin in the subarachnoid space. Ann Neurol 54: 591-598, 2003.
20. Poulain DA, Brown D, and Wakerly JB. Statistical analysis of patterns of electrical activity in vasopressin and oxytocin-secreting neurones. In: Pulsatility in Neuroendocrine Systems, edited by Leng G, Boca Raton, FL: CRC, 1998, p. 119-154.
21. Pow DV. NADPH-diaphorase activity (nitric oxide synthase) staining in the rat supraoptic nucelus in activity-dependent: possible functional implications. J Neuroendocrinol 4: 377-380, 1992.
22. Rafols D, Steiner J, Rafols JA, and Petrov T. Entracellular coexpression of endothelin-1 and inducible nitric oxide synthase underlies hypoperfusion after traumatic brain injury in the rat. Neurosci Lett 362: 154-157, 2004.
23. Ritz MF, Stuenkel EL, Dayanithi G, Jones R, and Nordmann JJ. Endothelin regulation of neuropeptide release from nerve endings of the posterior pituitary. Neurobiology 89: 8371-8375, 1992.
24. Rossi NF. Effect of endothelin-3 on vasopressin release in vitro and water excretion in vivo in Long Evans rats. J Physiol 461: 501-511, 1993.
25. Rossi NF. Cation channel mechanisms in endothelin 3-induced vasopressin secretion by rat hypothalamo-neurohypophysial explants. Am J Physiol Endocrinol Metab 268: E467-E475, 1995.
26. B receptors in compartmentalized rat hypothalamo-neurohypophysial explants. Am J Physiol Endocrinol Metab 286: E535-E541, 2004.
27. Rossi NF, Black SM, Telemaque-Potts S, and Chen H. Neuronal nitric oxide synthase activity in the paraventricular nucleus buffers central endothelin-1-induced pressor response and vasopressin secretion. J Cardiovasc Pharmacol 44: S283-S288, 2004.
28. B-R induced AVP secretion by NMDA and GABA mechanisms in hypothalamo-neurohypophysial explants. Clin Sci 103 Suppl 48: 162S-166S, 2002.
29. Rossi NF, O'Leary DS, and Chen H. Mechanisms of centrally administered endothelin 1-induced increases in systemic arterial pressure and AVP secretion. Am J Physiol Endocrinol Metab 272: E126-E132, 1997.
30. Rossi NF, O'Leary DS, Scislo TJ, Caspers ML, and Chen H. Central endothelin 1 regulation of arterial pressure and arginine vasopressin secretion via the AV3V region. Kidney Int 52 Suppl 61: S22-S26, 1997.
31. Rossi NF and Schrier RW. Anti-calmodulin agents affect osmotic and angiotensin II-induced vasopressin release. Am J Physiol Endocrinol Metab 256: E516-E523, 1989.
32. Sagar SM and Ferriero DM. NADPH diaphorase activity in the posterior pituitary: relation to neuronal function. Brain Res 400: 348-352, 1987.
33. Shesely EG, Gilbert C, Granderson G, Carretero CD, Carretero OA, and Beierwaltes WH. Nitric oxide synthase gene knockout mice do not become hypertensive during pregancy. Am J Obstet Gynecol 185: 1198-1203, 2001.
34. Shichiri M, Hirata Y, Kanno K, Ohta K, Emori T, and Marumo F. Effect of endothelin-1 on release of arginine vasopressin from perifused rat hypothalamus. Biochem Biophys Res Commun 163: 1332-1337, 1989.
35. Seidel PJ, Huang PL, and Wolf G. Differential expression of alternatively spliced isoforms of neuronal nitric oxide syntehase (nNOS) and N-methyl-D-aspartate receptors (NMDAR) in knockout mice deficient in nNOS alpha. Brain Res Mol Brain Res 28: 13-23, 2000.
36. Sladek CD and Knigge KM. Cholinergic stimulation of vasopressin release from the rat neurohypophyseal system in organ culture. Endocrinology 101: 411-420, 1977.
37. Srisawat R, Ludwig M, Bull PM, Douglas JJ, Russel JA, and Leng G. Nitric oxide and the oxytocin system in pregnancy. J Neurosci 20: 6721-6727, 2000.
38. Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam HC, O'Halloran DJ, and Bloom SR. Endothelin in human brain and pituitary gland: presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 72: 693-699, 1991.
39. Wang H and Morris JF. Constitutive nitric oxide synthase in hypothalami of normal and hereditary diabetes insipidus rats and mice: role of nitric oxide in osmotic regulation and its mechanism. Endocrinology 137: 1745-1751, 1996.
40. Wiley KE and Davenport AP. Nitic oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol 132: 213-220, 2001.
41. Yamamoto S, Inenaga K, Kannan H, Eto S, and Yamashita H. The actions of endothelin on single cells in the anteroventral third ventricular region and supraoptic nucleus in rat hypothalamic slices. J. Neuroendocrinology 5: 427-434, 1993.
42. Yamada K, Emson P, and Hofelt T. Immunohistochemical mapping of nitric oxide synthase in the rat hypothalamus and colocalization with neuropeptides. J Chem Neuroanat 10: 295-316, 1996.
43. Yamamoto T and Uemura H. Distribution of endothelin-B receptor-like immunoreactivity in rat brain, kidney and pancreas. J Cardiovasc Pharmacol 31 Suppl1: S207-S211, 1998.
44. A receptors. Neuroendocrinology 60: 553-558, 1994.
45. Yoshizawa T, Shinmi O, Giaid A, Yanagisawa M, Gibson SJ, Kimura S, Uchiyama Y, Polak JM, Masaki T, and Kanazawa I. Endothelin: a novel peptide in the posterior pituitary system. Science 247: 462-464, 1990.